Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

6.790 +0.680 (+11.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

23 Stocks Moving in Friday's Pre-Market Session ↗

February 11, 2022

Gainers Modular Medical Inc (NASDAQ: MODD) rose 321% to $15.64 in pre-market trading. Modular Medical, on Thursday, reported pricing of $15 million public offering...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 10, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI)...

Via Benzinga

Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th ↗

February 09, 2022

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...

Via Benzinga

Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis ↗

February 08, 2022

Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates for Osteoarthritis and other pain indications.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 08, 2022

Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 07, 2022

Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22....

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 04, 2022

Gainers Quidel (NASDAQ:QDEL) shares incre...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 01, 2022

Gainers Epizyme (NASDAQ:EPZM) shares incr...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 28, 2022

Gainers Enveric Biosciences (NASDAQ:ENVB)...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 27, 2022

Gainers Avidity Biosciences (NASDAQ:RNA) s...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 18, 2022

Gainers DBV Technologies (NASDAQ:DBVT) sh...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 07, 2022

Gainers ContraFect (NASDAQ:CFRX) stock mo...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 06, 2022

Gainers ContraFect (NASDAQ:CFRX) stock in...

Via Benzinga

Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021! ↗

January 02, 2022

Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the...

Via Talk Markets

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 16, 2021

Gainers Eloxx Pharmaceuticals (NASDAQ:

Via Benzinga

18 Stocks Moving in Thursday's Pre-Market Session ↗

December 16, 2021

Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO...

Via Benzinga

Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline ↗

December 12, 2021

The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same...

Via Talk Markets

Topics Cannabis

Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises ↗

December 10, 2021

Texas NORML Director Hired To Oversee State Policy Reform Efforts The National Organization for the Reform of Marijuana Laws (N...

Via Benzinga

Topics Cannabis

Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November ↗

December 01, 2021

A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.

Via Talk Markets

Topics Cannabis

Enveric Biosciences' CBD-Based Product Reduces Dermatitis Severity In Animal Study ↗

November 18, 2021

Enveric Biosciences (NASDAQ: ENVB) announced data from a preclinical rodent model evaluating EV102, the company's cannabidiol (CBD) based product in...

Via Benzinga

Earnings Scheduled For November 16, 2021 ↗

November 16, 2021

Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (...

Via Benzinga

EXCLUSIVE: Benzinga Interviews Mind Cure CEO Kelsey Ramsden with Updates on Latest Press Release ↗

November 09, 2021

Image by: iStock The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored conte...

Via Benzinga

Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health ↗

October 05, 2021

Photo by Christina Victoria Craft on Unsplash The world is finally waking up to the importance of mental health. It is becoming more acceptable to talk about mental illness....

Via Benzinga

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

The Week In Psychedelics

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 05, 2021

Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4...

Via Benzinga

September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances ↗

October 01, 2021

Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference ↗

September 30, 2021

The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. ...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 30, 2021

Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The company's market cap stands at $1.4 billion....

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions